Senestech Inc Stock Price, News & Analysis

SenesTech (NASDAQ: SNES) announced that Baltimore is expanding its deployment of Evolve™, the company's non-lethal rodent birth control product, following a successful pilot program. The city will implement Evolve™ more broadly in areas that showed measurable improvements during initial testing, integrating it into their existing pest management protocols. Evolve™, an EPA-classified minimum-risk pesticide, works by targeting rodent reproduction through a palatable soft bait that limits fertility in both male and female rodents. The product is designed to complement traditional pest control methods and poses no known risks to people, pets, or the environment when used as directed. Baltimore's pest control personnel reported enhanced results when incorporating Evolve™ into their existing protocols. SenesTech will provide ongoing support, including training and technical assistance throughout the rollout.

SenesTech (NASDAQ: SNES) has announced a significant distribution agreement with Bradley Caldwell, Inc. (BCI), a major wholesale distributor serving over 8,000 farm, ranch, hardware, and pet supply dealers across the United States. The partnership will distribute SenesTech's Evolve Rodent Birth Control products through BCI's extensive rural retail network. BCI, founded in 1930 and based in Hazleton, Pennsylvania, has placed the largest distributor stocking order in SenesTech's history. The strategic partnership aims to expand Evolve's market presence in agricultural communities where rodent infestations pose significant economic challenges, offering a humane alternative to traditional rodenticides.

SenesTech (NASDAQ: SNES), a company specializing in fertility control solutions for rodent population management, has announced its participation in the upcoming Lytham Partners Spring 2025 Investor Conference. The virtual event will take place on May 29, 2025, featuring a webcast fireside chat at 3:30 p.m. ET. The company's management will also be available for one-on-one meetings with investors throughout the conference. Interested participants can access the webcast through the conference website or register for individual meetings with management through Lytham Partners.

SenesTech (NASDAQ: SNES) reported strong Q1 2025 financial results, with total revenue increasing 17% to $485,000. The company's flagship Evolve™ product line saw 40% year-over-year growth, representing 79% of total revenue. Gross profit margins reached a record 64.5%, up from 32.5% in Q1 2024. Net loss improved to $1.7 million from $1.8 million year-over-year. The company has implemented cost reductions expected to save $2 million annually starting Q2 2025, lowering the breakeven revenue threshold from $12 million to $7 million. SenesTech expanded its municipal presence across major U.S. cities, including Chicago and New York City, while establishing international distribution in eleven countries. E-commerce revenue doubled with a 107% increase across major platforms.

SenesTech (SNES) has secured an exclusive distribution agreement with Asa Jaya Mandiri (AJM) for Evolve™ Soft Bait in Indonesia, marking its 11th international distribution partnership. The agreement targets Indonesia's palm oil industry, where rat infestations cause significant economic damage, reducing yields by 5-10% annually. With Indonesia's palm oil market valued at $10.8 billion in 2024, these losses amount to $540 million to $1.08 billion yearly. The partnership includes a substantial initial order and annual minimum purchase requirements to maintain exclusivity. AJM, a prominent Indonesian trading company with specialized pest management operations, will distribute SenesTech's fertility control solution to address the persistent challenge of rat populations in palm oil plantations.

SenesTech (NASDAQ: SNES) has announced it will release its first quarter 2025 financial results on Thursday, May 8, 2025, after the market close. The company will host a conference call the same day at 5:00 p.m. Eastern time to discuss the results for the period ended March 31, 2025.

Investors can join the conference call by dialing (844) 308-3351 or (412) 317-5407. A live webcast will be available through the company's Investor Relations website. A teleconference replay will be accessible for seven days, while the webcast replay will remain available for 90 days in the Investor Relations section.

SenesTech (Nasdaq: SNES) has expanded the deployment of its Evolve™ Rat Birth Control solution in Chicago's Wicker Park Bucktown Special Service Area. The program, implemented by the Wicker Park Bucktown Chamber of Commerce, involves installing bait boxes in neighborhood alleys to control rat populations without using harmful toxins or poisons.

The Chicago deployment follows significant urban implementations, including a rat contraceptive pilot program approved by the New York City Council in September, as well as deployments in Boston and Baltimore. The initiative aims to protect other animals and water supplies while effectively managing rodent populations.

Alice Howe, Special Service Area N. 33 Program Manager, is overseeing the program, while SenesTech's CEO Joel Fruendt reports positive early consumption rates and plans for expanding the deployment area with a second shipment already in progress. The company has also launched an informational website for local residents and business owners.

SenesTech (NASDAQ: SNES), a leader in fertility control solutions for rodent population management, has announced its participation in the Lytham Partners 2025 Industrials & Basic Materials Investor Summit. The company will engage in a virtual fireside chat on Tuesday, April 1, 2025, at 3:00 p.m. ET.

The event will be accessible through the conference website at lythampartners.com/ibmsummit25/ or directly via lythampartners.com/ibmsummit25/snes/. A replay option will be available through the same links. Additionally, interested parties can schedule one-on-one investor meetings following the event by reaching out to Lytham Partners representatives.

SenesTech (NASDAQ: SNES) reported strong Q4 2024 financial results, with revenue increasing 70% to $501,000 compared to Q4 2023. The company achieved a 60.9% gross profit margin, up from 43.7% in Q4 2023, while reducing operating expenses by 16%. Net loss decreased to $1.3 million from $1.7 million year-over-year.

The company's Evolve™ Rat product line contributed 52% of Q4 2024 revenue, while the newly launched Evolve™ Mouse accounted for 24%. E-commerce sales grew 206%, with successful launches on major platforms including Amazon and Walmart. The company has expanded internationally into 10 countries and secured municipal programs in several U.S. cities.

SenesTech announced new optimization initiatives expected to reduce expenses by $2 million annually, lowering the revenue threshold for cash flow breakeven from $12 million to approximately $7 million. The company's cash position stood at $1.3 million as of December 31, 2024, with an additional $2 million raised in Q1 2025 through ATM facility and warrant exercises.